LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares S&P 500 Growth ETF
IVW
|
+$372M |
| 2 |
Apple
AAPL
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$229M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
+$223M |
| 5 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$190M |
Top Sells
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$121M |
| 2 |
iShares ESG Aware MSCI USA ETF
ESGU
|
+$66.7M |
| 3 |
Vanguard Total Bond Market
BND
|
+$66.6M |
| 4 |
Health Care Select Sector SPDR Fund
XLV
|
+$61.6M |
| 5 |
iShares Global Energy ETF
IXC
|
+$60.3M |
Sector Composition
| 1 | Technology | 8.16% |
| 2 | Financials | 3.17% |
| 3 | Healthcare | 2.8% |
| 4 | Consumer Discretionary | 2.64% |
| 5 | Industrials | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4626
Biomea Fusion
BMEA
$109M
| $108K | ﹤0.01% |
24,094
-30,375
| -56% | -$137K |
|
4627
Newmark Group
NMRK
$3.33B
| $108K | ﹤0.01% |
10,580
-16,246
| -61% | -$166K |
|
4628
FinWise Bancorp
FINW
$259M
| $108K | ﹤0.01% |
10,595
-1,500
| -12% | -$15.3K |
|
4629
Taysha Gene Therapies
TSHA
$887M
| $108K | ﹤0.01% |
48,060
+5,998
| +14% | +$13.4K |
|
4630
Genelux
GNLX
$138M
| $108K | ﹤0.01% |
55,177
+9,215
| +20% | +$18K |
|
4631
Trevi Therapeutics
TRVI
$1.17B
| $107K | ﹤0.01% |
36,000
| – | – |
|
4632
Titan International
TWI
$546M
| $107K | ﹤0.01% |
+14,418
| New | +$107K |
|
|
GLO
4633
Clough Global Opportunities Fund
GLO
$241M
| $105K | ﹤0.01% |
19,480
+3,877
| +25% | +$20.9K |
|
4634
Oramed Pharmaceuticals
ORMP
$95.5M
| $104K | ﹤0.01% |
40,471
-5,130
| -11% | -$13.2K |
|
|
SRTA
4635
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$326M
| $104K | ﹤0.01% |
29,783
-297
| -1% | -$1.03K |
|
|
CCIF
4636
Carlyle Credit Income Fund
CCIF
$122M
| $103K | ﹤0.01% |
12,622
+1,732
| +16% | +$14.2K |
|
|
NAGE
4637
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $103K | ﹤0.01% |
37,791
| – | – |
|
4638
Lexicon Pharmaceuticals
LXRX
$392M
| $103K | ﹤0.01% |
61,085
-28,878
| -32% | -$48.5K |
|
4639
Aurora
AUR
$10B
| $102K | ﹤0.01% |
36,947
+10,061
| +37% | +$27.9K |
|
4640
C4 Therapeutics
CCCC
$188M
| $102K | ﹤0.01% |
+22,100
| New | +$102K |
|
4641
Seres Therapeutics
MCRB
$154M
| $102K | ﹤0.01% |
7,031
+542
| +8% | +$7.85K |
|
|
SLI
4642
Standard Lithium
SLI
$582M
| $101K | ﹤0.01% |
81,047
+12,325
| +18% | +$15.4K |
|
4643
Medallion Financial
MFIN
$244M
| $101K | ﹤0.01% |
13,175
-500
| -4% | -$3.84K |
|
4644
IAMGOLD
IAG
$6.27B
| $101K | ﹤0.01% |
+26,919
| New | +$101K |
|
|
BRKL
4645
DELISTED
Brookline Bancorp
BRKL
| $100K | ﹤0.01% |
+12,009
| New | +$100K |
|
4646
Enel Chile
ENIC
$5.02B
| $100K | ﹤0.01% |
35,793
-5,940
| -14% | -$16.6K |
|
4647
Amicus Therapeutics
FOLD
$2.45B
| $100K | ﹤0.01% |
+10,096
| New | +$100K |
|
4648
Ring Energy
REI
$215M
| $98.9K | ﹤0.01% |
58,538
+3,838
| +7% | +$6.49K |
|
4649
DarioHealth
DRIO
$18.3M
| $98.5K | ﹤0.01% |
4,140
-505
| -11% | -$12K |
|
4650
Matinas BioPharma
MTNB
$9M
| $96.9K | ﹤0.01% |
12,247
| – | – |
|